This is extremely promising for csl112. Even if it misses primary endpoint it can still be given fda approval?
https://endpts.com/failed-pivotal-study-you-can-still-have-breakthrough-therapy-status-fda-signals-to-resverlogix/
- Forums
- ASX - By Stock
- CSL
- Dont forget about CSL112!!!
Dont forget about CSL112!!!, page-23
Featured News
Add CSL (ASX) to my watchlist
|
|||||
Last
$295.56 |
Change
-4.190(1.40%) |
Mkt cap ! $142.8B |
Open | High | Low | Value | Volume |
$299.64 | $300.03 | $294.81 | $174.3M | 587.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2500 | $295.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$295.56 | 688 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2500 | 295.500 |
1 | 100 | 295.250 |
5 | 767 | 295.000 |
1 | 81 | 294.960 |
1 | 30 | 294.850 |
Price($) | Vol. | No. |
---|---|---|
295.770 | 75 | 1 |
295.840 | 13 | 1 |
295.930 | 952 | 1 |
295.940 | 100 | 1 |
296.000 | 195 | 1 |
Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |